©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8393-8406
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8393
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8393
Table 4 Outcome characteristics of patients with alcoholic liver disease and nonalcoholic fatty liver disease
| Outcomes | ALD | NAFLD | Ref. |
| Hepatocarcinogenesis | |||
| Incidence rate | |||
| Simple hepatic steatosis/steatohepatitis | 0%-0.2% per year | [115] | |
| Steatohepatitis/cirrhosis | 0.3%-4.3% per year | [115] | |
| Compensated cirrhosis | 0.7% per year | [90] | |
| Decompensated cirrhosis | 1.4% per year | [91] | |
| Compensated/decompensated cirrhosis | 2.5% per year | 2.1% per year | [96] |
| Unknown stage | 0.043% per year | [95] | |
| Prevalence rate of non-cirrhotic liver as underlying liver disease | 5.3%-12.0% | 25.0%-58.3% | [116-118] |
| Comparison of survival | Similar to non-ALD, NBNC HCC | Better than ALD- or HCV-related HCC | [119,120] |
| Hepatic decompensation | |||
| Incidence rate | |||
| Compensated cirrhosis | 4.4% per year | 4.5% per year | [90,121] |
| Mortality (overall) | |||
| Incidence rate | |||
| Simple hepatic steatosis | 3.3% per year | [52] | |
| Steatohepatitis | 5.0% per year | [52] | |
| Steatohepatitis/cirrhosis | 1.8% per year | [100] | |
| Compensated cirrhosis | 3.2% per year | [90] | |
| Decompensated cirrhosis | 5.7%-6.0% per year | [91,97] | |
| Compensated/decompensated cirrhosis | 5.0% per year | [124] | |
| Compared with liver diseases due to other causes | Similar to HCV-related compensated liver disease | [100] | |
| Similar to HCV-related compensated cirrhosis | Better than HCV-related compensated cirrhosis | [90,122] | |
| Similar to HCV-related decompensated cirrhosis | Similar to HCV-related decompensated cirrhosis | [91,122] | |
| Similar to HCV-related cirrhosis | [124] | ||
| Improved survival | Abstinence | [123] | |
| Causes of death | |||
| Simple hepatic steatosis | [55] | ||
| Liver-related causes | 17% | 2% | |
| Arteriosclerosis | 20% | 38% | |
| Extrahepatic malignancy | 14% | 17% | |
| Infection | 3% | 8% | |
| Cirrhosis | [90,97,98,122,124] | ||
| HCC | 10%-13% | 6.9%-47.4% | |
| Liver failure | 25%-60% | 17.2%-31.6% | |
| Cardiovascular disease | 1% | 27.6% | |
| Cerebrovascular disease | 1%-4% | ||
| Infection | 8.9%-25% | 41.4% | |
| Extrahepatic malignancy | 8%-25% |
- Citation: Toshikuni N, Tsutsumi M, Arisawa T. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8393-8406
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8393.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8393